TOCILIZUMAB & ABATACEPT WERE ASSOCIATED WITH LOWER RISK OF CARDIOVASCULAR EVENTS THAN RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS FAILING TUMOR NECROSIS FACTOR INHIBITORS IN A NATIONAL STUDY

Ming-Jer Hsieh, Shang-Hung Chang

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)1777-1777
JournalJournal of the American College of Cardiology
Volume73
Issue number9
DOIs
StatePublished - 2019

Cite this